Efficacy and Safety of Silodosin for the Treatment of Female <scp>LUTS</scp>: A 12‐Week Prospective, Single‐Center Study
Silodosin demonstrates efficacy and safety in treating female patients with moderate-to-severe LUTS, suggesting that it can be considered a viable treatment option alongside established therapies. Further studies are warranted to confirm these findings.
Authors
- Chung Beum Wee (ORCID: https://orcid.org/0009-0003-3698-0311)
- Tae‐Hyoung Kim (ORCID: https://orcid.org/0000-0002-0257-3449)
- Jong Hyun Tae (ORCID: https://orcid.org/0000-0001-5826-3469)
- Se Young Choi (ORCID: https://orcid.org/0000-0002-4615-0966)
Institutions
- Chung-Ang University Hospital (KR)
Publication Details
- Journal
- LUTS Lower Urinary Tract Symptoms
- Published
- 2025-01-01
- DOI
- https://doi.org/10.1111/luts.70005
- Citations
- 2
- Primary Topic
- Diagnosis and Treatment of Venous Diseases
- Type
- article
- Field-Weighted Citation Impact
- 4.01
Funders
- National Research Foundation of Korea